Orthodontic Treatment With a Part-Time Wearing Esthetic Removable Appliance

Sponsor
Hadassah Medical Organization (Other)
Overall Status
Unknown status
CT.gov ID
NCT00485602
Collaborator
(none)
20
1

Study Details

Study Description

Brief Summary

The trial is aimed to investigate an orthodontic treatment with a new removable-part-time-wearing appliance, based on "High-Tech" technology.

The appliance should be wear only 12-14 hours a day, and is made of a single silicone aligner, made specifically for the patient, using 3-D screening technology of the patient's malocclusion. The aligner has a designed pathway "built-in" for the tooth to move, from the original position of the malocclusion to the "end point" - the correct position.

The force system, that is needed in order to generate tooth movement, is produced by tiny air-balloons which are incorporated in the aligner.

The study hypothesis is, that an orthodontic treatment can be done successfully with this part-time wearing appliance.

Condition or Disease Intervention/Treatment Phase
  • Procedure: orthodontic treatment with "Rafenalign" appliance
Phase 1/Phase 2

Detailed Description

The appliance include:
  • silicone aligner (made specifically for the patient.

  • simple air pump to blow air in the tiny balloons.

The patient is guided to wear the appliance 12-14 hours a day, after filling air in the balloons, under the doctor's instructions.

Clinical examination for follow-up will be done every 4 weeks.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Study Start Date :
Dec 1, 2007

Outcome Measures

Primary Outcome Measures

  1. study models [every 2 appointments (8 weeks)]

Secondary Outcome Measures

  1. occlusal photographs [every 3 appointments (12 weeks)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 68 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • mild to moderate class I malocclusion

  • good general health

  • good oral hygiene

Exclusion Criteria:
  • bad cooperation

  • any mental or health problem

  • severe class I malocclusion, class II or class III malocclusion

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hadassah Medical Organization Jerusalem Israel 91120

Sponsors and Collaborators

  • Hadassah Medical Organization

Investigators

  • Principal Investigator: Meir Redlich, Hadassah Medical Organization

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00485602
Other Study ID Numbers:
  • RAFENALIGN-HMO-CTIL
First Posted:
Jun 13, 2007
Last Update Posted:
Jun 13, 2007
Last Verified:
Jun 1, 2007
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 13, 2007